LDN Low Dose Naltrexone 3mg

Low Dose Naltrexone (LDN) 3 mg Capsules

Product Description:

LDN 3 mg Capsules contain Low Dose Naltrexone (LDN), a formulation of the opioid receptor antagonist Naltrexone administered at a low dose (3 mg) to support the management of various autoimmune and inflammatory conditions, as well as certain chronic pain syndromes. Unlike standard doses used for alcohol and opioid dependence, this low dose is intended to modulate immune function and promote endorphin release, which may contribute to symptom relief in select patient populations.

While its use for these conditions is considered off-label, growing anecdotal and clinical interest supports its inclusion in integrative treatment strategies.

Off-Label Indications:

• Multiple Sclerosis (MS)

• Crohn’s Disease

• Rheumatoid Arthritis

• Hashimoto’s Thyroiditis

• Chronic Fatigue Syndrome (CFS)

• Fibromyalgia

• Autoimmune skin conditions (e.g., psoriasis, eczema)

• Neuropathic and chronic pain syndromes

Mechanism of Action:

Low-dose Naltrexone temporarily blocks opioid receptors, which triggers a rebound increase in endorphin production. This elevation in endogenous opioids is believed to enhance immune regulation, reduce pro-inflammatory cytokines, and improve symptoms in inflammatory and autoimmune disorders.

Key Features:

• Mid-range low-dose formulation (3 mg), commonly used for maintenance dosing

• Available in 1.5 mg, 3 mg, and 4.5 mg strengths

• Convenient strip packaging: 10 capsules per strip

• Manufactured under strict pharmaceutical guidelines

• Typically well-tolerated with a favorable safety profile